Whole Body Treatment Archives

01 September, 2022

Testing the in vivo efficacy of base and prime editing in primary fibroblasts and in a 3D skin model of dystrophic epidermolysis bullosa...

01 May, 2022

Rigosertib for recessive dystrophic epidermolysis bullosa-associated squamous cell carcinoma...

01 April, 2021

Testing the efficacy of genomic base editing in dystrophic epidermolysis bullosa primary fibroblasts...

01 January, 2021

Development of a topical gene-editing treatment to restore Collagen VII...

01 March, 2019

Development of IV-administered siRNAs targeting mutant KRT5 and KRT1 in EB Simplex...

01 January, 2018

Gene editing for Epidermolysis Bullosa...

01 May, 2017

Epidermolysis Bullosa Therapeutic Reprogramming Consortium...

01 December, 2016

Next generation genome editing for Recessive Dystrophic Epidermolysis Bullosa...

01 October, 2015

Deep sequencing Recessive Dystrophic Epidermolysis Bullosa squamous cell carcinoma...

01 July, 2015

Mensenchymal stromal cells engineered to express Collagen VII for the treatment of Recessive Dystrophic Epidermolysis Bullosa...

Archive